ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,806.27
0.34%
Gold vs US Dollar
2,327.88
1.48%
Brent Oil
83.395
0.32%
Bitcoin
64,030.42
0.05%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Bivictrix Therapeutics Plc (BVX)

  7. Bivictrix Therapeutics Plc (BVX) News

Bivictrix Therapeutics (BVX)

Bivictrix Therapeutics Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:BVX
DateTimeSourceHeadlineSymbolCompany
17/04/202414:23Alliance NewsAlliance NewsBivictrix granted FDA orphan drug status for rare cancer treatmentLSE:BVXBivictrix Therapeutics Plc
17/04/202407:00RNS Regulatory NewsBiVictriX Therapeutics PLC Orphan Drug Designation & FDA INTERACT MeetingLSE:BVXBivictrix Therapeutics Plc
28/03/202407:00RNS Regulatory NewsBiVictriX Therapeutics PLC Grant of Options – PDMR/Director DealingsLSE:BVXBivictrix Therapeutics Plc
04/01/202412:30UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
04/01/202412:30UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
04/01/202407:00UK RegulatoryBiVictriX Therapeutics PLC BiVictriX Hosts Inaugural Roundtable DiscussionLSE:BVXBivictrix Therapeutics Plc
05/12/202311:08UK RegulatoryBiVictriX Therapeutics PLC Board ChangeLSE:BVXBivictrix Therapeutics Plc
30/11/202312:08Alliance NewsAlliance NewsIN BRIEF: Bivictrix selects final sequences for lead tumour programmeLSE:BVXBivictrix Therapeutics Plc
30/11/202307:00UK RegulatoryBiVictriX Therapeutics PLC Pipeline update on BVX002LSE:BVXBivictrix Therapeutics Plc
22/11/202317:14UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
15/11/202313:05Alliance NewsAlliance NewsTRADING UPDATES: BiVictriX patent boost; 4Global deal extendedLSE:BVXBivictrix Therapeutics Plc
15/11/202307:00UK RegulatoryBiVictriX Therapeutics PLC Patent Granted in JapanLSE:BVXBivictrix Therapeutics Plc
12/10/202312:04Alliance NewsAlliance NewsBivictrix says BVX001 increases survival rates by more than doubleLSE:BVXBivictrix Therapeutics Plc
12/10/202307:00UK RegulatoryBiVictriX Therapeutics PLC Extended Survival Rates Reported with BVX001LSE:BVXBivictrix Therapeutics Plc
03/10/202312:06Alliance NewsAlliance NewsBivictrix hires new CFO as Alex Hughes steps down after seven monthsLSE:BVXBivictrix Therapeutics Plc
03/10/202307:00UK RegulatoryBiVictriX Therapeutics PLC Appointment of Adrian Howd as CFO and CBOLSE:BVXBivictrix Therapeutics Plc
19/09/202317:30Alliance NewsAlliance NewsTRADING UPDATES: AEW UK REIT appoints new chair; Oberon raises moneyLSE:BVXBivictrix Therapeutics Plc
19/09/202307:00UK RegulatoryBiVictriX Therapeutics PLC Interim ResultsLSE:BVXBivictrix Therapeutics Plc
31/08/202307:00UK RegulatoryBiVictriX Therapeutics PLC Total Voting RightsLSE:BVXBivictrix Therapeutics Plc
23/08/202309:30Alliance NewsAlliance NewsBivictrix Therapeutics granted US patent for cancer drug BVX001LSE:BVXBivictrix Therapeutics Plc
23/08/202307:00UK RegulatoryBiVictriX Therapeutics PLC US Patent GrantedLSE:BVXBivictrix Therapeutics Plc
17/08/202307:00UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
16/08/202318:00UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
11/08/202316:17UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
08/08/202317:18UK RegulatoryBiVictriX Therapeutics PLC Result of General MeetingLSE:BVXBivictrix Therapeutics Plc
19/07/202319:30Alliance NewsAlliance NewsUPDATE: Bivictrix Therapeutics raises GBP2.1 million through fundraiseLSE:BVXBivictrix Therapeutics Plc
19/07/202318:16UK RegulatoryBiVictriX Therapeutics PLC Result of Conditional FundraiseLSE:BVXBivictrix Therapeutics Plc
19/07/202314:12Alliance NewsAlliance NewsIN BRIEF: Bivictrix to raise more than GBP2 million via placingLSE:BVXBivictrix Therapeutics Plc
19/07/202312:31UK RegulatoryBiVictriX Therapeutics PLC Proposed Fundraise in excess of GBP2 millionLSE:BVXBivictrix Therapeutics Plc
17/07/202313:57Alliance NewsAlliance NewsBivictrix Therapeutics hails positive data in final leukaemia studyLSE:BVXBivictrix Therapeutics Plc
 Showing the most relevant articles for your search:LSE:BVX

Your Recent History

LSE
POS
Plexus
LSE
RR.
Rolls-royce
LSE
HUM
Hummingbird Resources
LSE
SBTX
Skinbiotherapeutics
LSE
SRSP
Sirius Petroleum
LSE
AAU
Ariana Resources
LSE
BIRD
Blackbird
LSE
SCE
Surface Transforms
LSE
AGL
Angle
LSE
LLOY
Lloyds Banking
LSE
ENET
Ethernity Networks
LSE
SOLG
Solgold
LSE
GFM
Griffin Mining
LSE
ASC
Asos
LSE
SCLP
Scancell
LSE
OBI
Ondine Biomedical
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved